Vishay Intertechnology-s New Ultra-Precision Thin Film MELF Resistor Is Industry-s First With TCR to +/- 5 ppm/K, Tolerance to +/- 0.02 %, and Operating Voltage of 350 V in 0207 Case Size

Vishay Intertechnology-s New Ultra-Precision Thin Film MELF Resistor Is Industry-s First With TCR to +/- 5 ppm/K, Tolerance to +/- 0.02 %, and Operating Voltage of 350 V in 0207 Case Size

MALVERN, PA — (Marketwired) — 12/03/13 — Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new series of high-precision thin film MELF resistors. Designed for demanding applications with high stability and reliability requirements, the Vishay Beyschlag UMB 0207 series devices are the industry-s first MELF resistors to offer low TCR down to +/- 5 ppm/K and tolerances down to +/- 0.02 % in the standard 0207 case size.The UMB 0207 series combines the proven reliability of professional

Astro-Med CEO Everett Pizzuti to Retire; Board Appoints Gregory Woods as Successor

Astro-Med CEO Everett Pizzuti to Retire; Board Appoints Gregory Woods as Successor

WEST WARWICK, RI — (Marketwired) — 12/02/13 — Astro-Med, Inc. (NASDAQ: ALOT), a manufacturer of specialty high tech printers and data acquisition systems, announces that its CEO, Everett V. Pizzuti, will retire effective January 31, 2014, the end of the Company-s current fiscal year.Mr. Pizzuti joined the Company in January of 1971 along with its founder, Albert W. Ondis. He held the position of President and COO until the passing of Mr. Ondis in July of 2011, at which time the Board appoint

Astro-Med, Inc. Reports Strong Sales and Earnings for the Fiscal Third Quarter; Directors Declare Regular Cash Dividend

Astro-Med, Inc. Reports Strong Sales and Earnings for the Fiscal Third Quarter; Directors Declare Regular Cash Dividend

WEST WARWICK, RI — (Marketwired) — 11/26/13 — Astro-Med, Inc. (NASDAQ: ALOT) reports Net Sales of $18,179,000 and Net Income of $1,108,000, equal to $0.14 per diluted share for the Third Quarter ended November 2, 2013. For the corresponding period of the prior year, the Company reported Net Sales of $16,039,000 and Net Income of $1,307,000, equal to $0.18 per diluted share. Net Income in the Third Quarter includes a tax benefit of $187,000 or $0.02 per diluted share, due to a favorable adjus

Hansen Medical to Present at 25th Annual Piper Jaffray Healthcare Conference

Hansen Medical to Present at 25th Annual Piper Jaffray Healthcare Conference

MOUNTAIN VIEW, CA — (Marketwired) — 11/25/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that Chief Financial Officer, Peter J. Mariani, is scheduled to present at the 25th Annual Piper Jaffray Healthcare Conference. The conference is being held December 3-4, 2013 at the Palace Hotel in New York, NY. Hansen Medical is scheduled to present on Wednesday, December 4, 2013 at 3:30 p.m. Eastern Time.Hansen Medical will provide a live webcast o

1 20 21 22 23 24 50